Our law firm is currently accepting new claims against the manufactures of the prescription drugs, over-the-counter medications, and dietary supplement products included in the list(s) below.
According to the preliminary results of an ongoing study, Boehringer Ingelheim’s new blood-thinning drug Pradaxa (dabigatran etexilate) may be substantially more dangerous than Coumadin (warfarin), the medication it was designed [...]
AstraZeneca’s widely-prescribed heartburn drug Nexium (esomeprazole magnesium) has recently been linked to bone fractures and bone breaks, particularly among users who have taken the drug over an extended period of [...]
Ten days after the U.S. Food & Drug Administration (FDA) sent letters to a number of dietary supplement manufacturers requesting safety information on their DMAA-containing products, a Harvard researcher is [...]
Canadian health regulators have announced that warning labels of the widely-prescribed antidepressant Lexapro (which is marketed in that country as Cipralex) will be updated to include information about abnormal heart [...]
As DMAA’s future regulatory status appears bleak, dietary supplement manufacturers are scrambling to come up with effective alternatives. But the question remains, will DMAA’s replacement be safe to use as [...]
Again, if you or a loved one have taken a prescription drug, over-the-counter drug or dietary supplement that has caused a serious, life-threatening side effect, you should contact us immediately. You may be entitled to compensation by filing a drug side effect lawsuit and we can help.
Attention Attorneys: Schmidt & Clark considers a referral from another law firm to be one of the greatest compliments. Our law firm has built a reputation for succsess and accepts a number of case referrals on a regular basis. We do not publish prior verdicts or settlements on our website. If you would like to refer us a case or for us to send you a profile of prior award judgments or average referral fees, please visit the attorney referral section of our website.